Biotransformation of valdecoxib by microbial cultures.

Microbial biotransformations can be used to predict mammalian drug metabolism. The present investigation deals with microbial biotransformation of valdecoxib using microbial cultures. Thirty-nine bacterial, fungal, and yeast cultures were used to elucidate the biotransformation pathway of valdecoxib. A number of microorganisms metabolized valdecoxib to various levels to yield nine metabolites, which were identified by HPLC—DAD and LC—MS—MS analyses. HPLC analysis of biotransformed products indicated that a majority of the metabolites are more polar than the substrate valdecoxib. Basing on LC— MS—MS analysis, the major metabolite was identified as a hydroxymethyl metabolite of valdecoxib, whereas the remaining metabolites were produced by carboxylation, demethylation, ring hydroxylation, N-acetylation, or a combination of these reactions. The hydroxymethyl and carboxylic acid metabolites were known to be produced in metabolism by mammals. From the results, it can be concluded that microbial cultures, particularly fungi, can be used to predict mammalian drug metabolism.

[1]  V. Ciddi,et al.  Determination of valdecoxib in serum using a HPLC-diode array detector and its application in a pharmacokinetic study. , 2006, Die Pharmazie.

[2]  D. Zhong,et al.  Biotransformation of tolbutamide to 4′-hydroxytolbutamide by the fungus Cunninghamella blakesleeana , 2006, Applied Microbiology and Biotechnology.

[3]  Yande Huang,et al.  STRUCTURAL ELUCIDATION OF HUMAN OXIDATIVE METABOLITES OF MURAGLITAZAR: USE OF MICROBIAL BIOREACTORS IN THE BIOSYNTHESIS OF METABOLITE STANDARDS , 2006, Drug Metabolism and Disposition.

[4]  G. Carter,et al.  ABT-963 [2-(3,4-Difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], A Highly Potent and Selective Disubstituted Pyridazinone Cyclooxgenase-2 Inhibitor , 2004, Journal of Pharmacology and Experimental Therapeutics.

[5]  M. Sari,et al.  Microbial oxidation of terfenadine and ebastine into fexofenadine and carebastine. , 2004, Bioorganic & medicinal chemistry letters.

[6]  H. Böttcher,et al.  Microbial oxidation of ebastine , 1996, Applied Microbiology and Biotechnology.

[7]  P. Davis,et al.  Microbial Models of Mammalian Metabolism: Stereoselective Metabolism of Warfarin in the Fungus Cunninghamella elegans , 2004, Pharmaceutical Research.

[8]  A. Carnell,et al.  The synthesis of buprenorphine intermediates by regioselective microbial N- and O-demethylation reactions using Cunninghamella echinulata NRRL 1384 , 2003 .

[9]  R. Bible,et al.  Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[10]  J. W. Findlay,et al.  Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[11]  F. Camu,et al.  Valdecoxib, a COX-2–Specific Inhibitor, Is an Efficacious, Opioid-Sparing Analgesic in Patients Undergoing Hip Arthroplasty , 2002, American journal of therapeutics.

[12]  E. Hammer,et al.  Biotransformation of Biphenyl by Paecilomyces lilacinus and Characterization of Ring Cleavage Products , 2001, Applied and Environmental Microbiology.

[13]  C. Koboldt,et al.  N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration. , 2000, Journal of medicinal chemistry.

[14]  R. S. Rogers,et al.  4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. , 2000, Journal of medicinal chemistry.

[15]  E. Abourashed,et al.  Microbial models of mammalian metabolism of xenobiotics: An updated review. , 1999, Current medicinal chemistry.

[16]  C. Cerniglia,et al.  Biotransformation of protriptyline by filamentous fungi and yeasts. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[17]  M. Pickard,et al.  Stereoselective metabolism of rac-mexiletine by the fungus Cunninghamella echinulata yields the major human metabolites hydroxymethylmexiletine and p-hydroxymexiletine. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[18]  J. Zamecnik,et al.  The biotransformation of tranylcypromine by Cunninghamella echinulata. , 1991, Canadian journal of microbiology.

[19]  A. Clark,et al.  Use of microorganisms for the study of drug metabolism: An update , 1991, Medicinal research reviews.

[20]  R. Furstoss,et al.  “Microbial transformations 18. Regiospecific para-hydroxylation of aromatic carbamates mediated by the fungus Beauveria sulfurescens” , 1991 .

[21]  D. L. Wilson,et al.  Effect of sparteine and quinidine on the metabolism of methoxyphenamine by Cunninghamella bainieri. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[22]  Walter A. Korfmacher,et al.  Microbial transformation of the antihistaminic drug triprolidine hydrochloride. , 1988, Journal of pharmaceutical sciences.

[23]  B. Foster,et al.  Microbial metabolism of phenelzine and pheniprazine. , 1988, Life sciences.

[24]  A. Clark,et al.  The use of microorganisms for the study of drug metabolism , 1985, Medicinal research reviews.

[25]  J. Golbeck,et al.  Metabolism of biphenyl by Aspergillus toxicarius: induction of hydroxylating activity and accumulation of water-soluble conjugates , 1983, Journal of bacteriology.

[26]  C. Cerniglia,et al.  Fungal metabolism of biphenyl. , 1979, The Biochemical journal.

[27]  D. Jerina,et al.  Monooxygenase activity in Cunninghamella bainieri: evidence for a fungal system similar to liver microsomes. , 1973, Archives of biochemistry and biophysics.